Kazuaki Niikura
Pharmacology Research Laboratories
Astellas Pharma Inc.
Japan
Name/email consistency: high
- FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats. Niikura, K., Nakajima, S., Takano, M., Yamazaki, H. Bone (2007)
- Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis. Niikura, K. Cancer Chemother. Pharmacol. (2007)
- Vacuolar ATPase as a drug discovery target. Niikura, K. Drug News Perspect. (2006)
- Comparative analysis of the effects of a novel vacuolar adenosine 5'-triphosphatase inhibitor, FR202126, and doxycycline on bone loss caused by experimental periodontitis in rats. Niikura, K. J. Periodontol. (2006)
- A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application. Niikura, K., Takeshita, N., Takano, M. J. Bone Miner. Res. (2005)
- A novel inhibitor of vacuolar ATPase, FR202126, prevents alveolar bone destruction in experimental periodontitis in rats. Niikura, K., Takeshita, N., Chida, N. J. Toxicol. Sci (2005)